Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Sees Slightly More Success With External Rx Than Internal Candidates

Executive Summary

Merck has a slightly higher success rate with drug candidates developed through external licensing deals than with internally discovered compounds, Merck Senior Director-Strategic Research Initiatives, External Scientific Affairs Ronald Newbold said

You may also be interested in...



Merck To Sign 50 Business Development Deals In 2005

Merck's goal is to sign about 50 business development deals in 2005, the same level as 2004, the company said

Merck To Sign 50 Business Development Deals In 2005

Merck's goal is to sign about 50 business development deals in 2005, the same level as 2004, the company said

Merck To Increase Internal R&D But Reduce Outside Deals In 2005

Merck expects to decrease its spending on product acquisition and licensing deals in 2005, the company told analysts during its Dec. 14 annual business review in Whitehouse Station, N.J

Related Content

UsernamePublicRestriction

Register

GB150348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel